BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25051378)

  • 1. Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected cases.
    Chen YL; Lu CC; Yang SC; Su WP; Lin YL; Chen WL; Huang W; Su WC; Chow NH; Ho CL
    J Mol Diagn; 2014 Sep; 16(5):486-494. PubMed ID: 25051378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
    Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M
    Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.
    Yoon SH; Choi YD; Oh IJ; Kim KS; Choi H; Chang J; Shin HJ; Park CK; Kim YC
    Cancer Res Treat; 2015 Oct; 47(4):661-9. PubMed ID: 25715768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
    Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ
    J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
    Yamada N; Oizumi S; Asahina H; Shinagawa N; Kikuchi E; Kikuchi J; Sakakibara-Konishi J; Tanaka T; Kobayashi K; Hagiwara K; Nishimura M
    Oncology; 2012; 82(6):341-6. PubMed ID: 22677909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations.
    Vliegen L; Dooms C; De Kelver W; Verbeken E; Vansteenkiste J; Vandenberghe P
    Diagn Pathol; 2015 May; 10():57. PubMed ID: 26022577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer.
    Houang M; Sioson L; Clarkson A; Watson N; Farzin M; Toon CW; Raut A; O'Toole SA; Cooper WA; Pavlakis N; Mead S; Chou A; Gill AJ
    Pathology; 2014 Oct; 46(6):501-8. PubMed ID: 25158821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer.
    Skronski M; Chorostowska-Wynimko J; Szczepulska E; Szpechcinski A; Rudzinski P; Orlowski T; Langfort R
    Adv Exp Med Biol; 2013; 756():321-31. PubMed ID: 22836650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.
    Sriram KB; Tan ME; Savarimuthu SM; Wright CM; Relan V; Stockwell RE; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
    Eur Respir J; 2011 Oct; 38(4):903-10. PubMed ID: 21349912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.
    He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J
    Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonenriched PCR Versus Mutant-Enriched PCR in Detecting Selected Epidermal Growth Factor Receptor Gene Mutations Among Nonsmall-Cell Lung Cancer Patients.
    Zaki MA; Ramadan RA; Mahmoud MI; El-Kaffash DM; Assaad RS
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):444-9. PubMed ID: 26043138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.
    Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M
    Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
    Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK
    Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer.
    He C; Zheng L; Xu Y; Liu M; Li Y; Xu J
    Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "COLD-PCR approach" for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer.
    Mairinger FD; Vollbrecht C; Streubel A; Roth A; Landt O; Walter HF; Kollmeier J; Mairinger T
    Appl Immunohistochem Mol Morphol; 2014; 22(2):114-8. PubMed ID: 24517913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for detection of mutation in epidermal growth factor receptor.
    Zhao J; Zhao J; Huang J; Chen Y; Jiang J; Wu W; Wang P; Liu L; Li L; Wu L; Wang M; Chen W
    Lung Cancer; 2011 Nov; 74(2):226-32. PubMed ID: 21439672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor mutations in 510 Finnish non--small-cell lung cancer patients.
    Mäki-Nevala S; Rönty M; Morel M; Gomez M; Dawson Z; Sarhadi VK; Telaranta-Keerie A; Knuuttila A; Knuutila S
    J Thorac Oncol; 2014 Jun; 9(6):886-91. PubMed ID: 24828666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
    Pasquale R; Fenizia F; Esposito Abate R; Sacco A; Esposito C; Forgione L; Rachiglio AM; Bevilacqua S; Montanino A; Franco R; Rocco G; Botti G; Denis MG; Morabito A; De Luca A; Normanno N
    Pharmacogenomics; 2015; 16(10):1135-48. PubMed ID: 26249748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
    Xu H; Sun W; Zhang G; Cheng Y
    J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.